MSD (Merck Sharp & Dohme) is one of the world’s most respected pharmaceutical companies, pioneering innovation across oncology, dermatology, and hormone therapy.
Its trusted portfolio includes Propecia® (Finasteride) for hair loss, Keytruda® (Pembrolizumab) for cancer immunotherapy, and Femilon® / Cerazette® / Novelon® for contraceptive and hormonal balance.
MSD is globally recognized for delivering cutting-edge therapies that redefine standards in both preventive and advanced medical care.